Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.400 | None | 1.000 | 24 | 0 | 1998 | 2019 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.400 | None | 1.000 | 11 | 0 | 2012 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 1.000 | 10 | 0 | 1993 | 2018 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.360 | None | 1.000 | 6 | 2 | 2003 | 2018 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.340 | None | 1.000 | 4 | 1 | 2006 | 2009 | ||||||||
|
UDP glucuronosyltransferase family 2 member B17 | 0.641 | 0.577 | 9.7E-08 |
|
disease | 0.320 | None | 0.667 | 2 | 0 | 2005 | 2011 | ||||||||
|
Janus kinase 3 | 0.505 | 0.731 | 5.9E-06 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.963 | 27 | 0 | 1993 | 2020 | ||||||||
|
calcineurin binding protein 1 | 0.536 | 0.846 | 3.3E-17 |
|
disease | 0.100 | None | 1.000 | 24 | 0 | 2009 | 2020 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 2002 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 1.000 | 17 | 1 | 1993 | 2019 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1993 | 2019 | ||||||||
|
forkhead box P3 | 0.368 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0.944 | 17 | 1 | 2004 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1994 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.100 | None | 0.867 | 15 | 2 | 1993 | 2020 | ||||||||
|
atrophin 1 | 0.409 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2007 | 2019 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 1998 | 2020 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2004 | 2017 | ||||||||
|
secretin | 0.484 | 0.846 | 1.4E-07 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2002 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2002 | 2018 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2004 | 2018 | ||||||||
|
GTP binding protein overexpressed in skeletal muscle | 0.467 | 0.769 | 1.2E-08 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2004 | 2019 | ||||||||
|
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 | 0.475 | 0.769 | 8.4E-14 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2004 | 2019 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2003 | 2018 |